Secondaries announced 3.26.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: TriplePoint Venture Growth BDC
Symbol: TPVG
Price: Last trade $14.73
Trade Date: 3/27
Shares: 6.5 million
Underwriter(s) Morgan Stanley, Wells Fargo, Goldman Sachs, UBS Securities
Rating=Subscription Needed

Company: Applied DNA Sciences
Symbol: APDN
Price: Last trade $3.16
Trade Date: 3/27
Shares: TBD
Underwriter(s) Maxim Group
Co Manager(s) The Benchmark Co.
Rating=Subscription Needed